Determination method of main drug content in omeprazole solid preparation
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHANGHAI SINE WANXIANG PHARMA
- Publication Date
- 2018-03-27
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the technical field of drug analysis and detection, in particular to a method for determining the content of the main drug in omeprazole solid preparations. Background technique
[0002] Peptic ulcer is a common and frequently-occurring disease, and about 5% to 6% of people in the world have suffered from it. 80sH + -K + -The advent of ATPase (proton pump) inhibitors has made a breakthrough in the treatment of peptic ulcer and has become the strongest new acid-suppressing drug. Proton pump inhibitors such as omeprazole have opened up a new way of action in the treatment of peptic ulcer, making the treatment of peptic ulcer no longer a difficult problem. Omeprazole is a benzimidazole proton pump inhibitor, which can inhibit the intramembrane proton pump (H + -K + -ATPase system), so that the H in the cell wall + It cannot be transported into the gastric juice, thus exerting the effect of inhibiting the secretion of gastric...